Agilent Technologies (A) : Analyst Rating Update

Agilent Technologies (A) : 10 analysts are covering Agilent Technologies (A) and their average rating on the stock is 1.8, which is read as a Buy. 6 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. A Zacks Investment Research rank of 2, which recommends a Buy affirms that they expect a large upside in the stock from the current levels. A total of 4 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

Agilent Technologies (A) stock is expected to deviate a maximum of $3.02 from the average target price of $49.38 for the short term period. 8 Street Experts have initiated coverage on the stock with the most promising target being $55 and the most muted being $45.

Agilent Technologies (NYSE:A): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $43.65 and $43.36 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $44.55. The buying momentum continued till the end and the stock did not give up its gains. It closed at $44.47, notching a gain of 1.65% for the day. The total traded volume was 2,312,133 . The stock had closed at $43.75 on the previous day.

Also, Equity Analysts at the Brokerage Firm, Cowen & Company, maintains their rating on the shares of Agilent Technologies (NYSE:A). Cowen & Company has a Outperform rating on the shares. As per the latest research report, the brokerage house raises the price target to $49 per share from a prior target of $47. The rating by the firm was issued on May 26, 2016. The company shares have rallied 12.90% from its 1 Year high price. On Jun 23, 2016, the shares registered one year high at $46.68 and the one year low was seen on Oct 2, 2015. The 50-Day Moving Average price is $45.11 and the 200 Day Moving Average price is recorded at $40.79.

Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.